We found that NDRG4 levels were significantly decreased in lung adenocarcinoma, but with regard to survival analysis, the expression of NDRG4 has shown no significant influence on survival rates of lung cancer patients. This evidence concerns the gene NDRG4 and lung adenocarcinoma.